If Genetically Modified Mosquitoes Freaked You Out, You Won't Like What's Coming – Gizmodo
12/13/2016
GizmodoIf Genetically Modified Mosquitoes Freaked You Out, You Won't Like What's ComingGizmodoIt's possible that something in the altered genetic code of male flies might act as a turnoff for female flies, reducing the effectiveness of the program, or that the new technology won't wind up being more cost-effective in the end. In Malaysia, where …and more »
12/13/2016
GizmodoIf Genetically Modified Mosquitoes Freaked You Out, You Won't Like What's ComingGizmodoIt's possible that something in the altered genetic code of male flies might act as a turnoff for female flies, reducing the effectiveness of the program, or that the new technology won't wind up being more cost-effective in the end. In Malaysia, where …and more »
Better Buy: Intrexon Corporation vs. bluebird bio – Motley Fool
12/13/2016
Motley FoolBetter Buy: Intrexon Corporation vs. bluebird bioMotley FoolAlthough the word "biotech" is often used interchangeably with "biopharma," biology as technology is not confined to healthcare applications. That's the message engineered biology conglomerate Intrexon (NYSE:XON) is trying to send out to investors …
12/13/2016
Motley FoolBetter Buy: Intrexon Corporation vs. bluebird bioMotley FoolAlthough the word "biotech" is often used interchangeably with "biopharma," biology as technology is not confined to healthcare applications. That's the message engineered biology conglomerate Intrexon (NYSE:XON) is trying to send out to investors …